Oxetane, 3-ethyl-3-propyl

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氧杂环丁烷
• 英文名称: Oxetane, 3-ethyl-3-propyl
• 英文别名: 3-ethyl-3-propyloxetane
• 化学式: C₈H₁₆O
• 分子量: 128.21
• InChiKey: HAJCTSOSULRGRA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• [EN] MACROCYCLIC AND BICYCLIC INHIBITORS OF HEPATITIS C VIRUS<br/>[FR] INHIBITEURS MACROCYCLIQUES ET BICYCLIQUES DU VIRUS DE L'HÉPATITE C
  申请人：GILEAD SCIENCES INC

  公开号：WO2014145095A1

  公开（公告）日：2014-09-18

  Compounds of formula (I):or pharmaceutically acceptable salts thereof, wherein the various substituents are defined herein, methods of using said compounds, and pharmaceutical compositions containing said compounds.

  式(I)的化合物或其药用可接受的盐，其中各种取代基在此定义，使用所述化合物的方法，以及含有所述化合物的药物组合物。
• PACKAGING MATERIAL HAVING BIREFRINGENT PATTERN
  申请人：TAKAHASHI Kouki

  公开号：US20100162666A1

  公开（公告）日：2010-07-01

  A packaging material, having at least one optically anisotropic layer which is made from substantially the same layer-forming composition and includes two or more regions different in birefringence property.

  一种包装材料，具有至少一层光学各向异性层，该层由基本相同的层形成组成，并包括两个或更多具有不同双折射性质的区域。
• INHIBITORS OF INFLUENZA VIRUSES REPLICATION
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20140142119A1

  公开（公告）日：2014-05-22

  Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

  抑制生物样品或患者中流感病毒复制的方法，减少生物样品或患者中流感病毒的数量，以及治疗患者的流感的方法，包括向所述生物样品或患者投予有效量的由结构式（I）表示的化合物或其药学上可接受的盐，其中结构式（IA）的值如此处所述。所述化合物由结构式（IA）或其药学上可接受的盐表示，其中结构式（IA）的值如此处所述。药物组合物包括有效量的此类化合物或其药学上可接受的盐，以及药学上可接受的载体、佐剂或载体。
• POLYMERS CONTAINING SUBSTITUTED TRIARYLAMINE UNITS AND ELECTROLUMINESCENT DEVICES CONTAINING SAID POLYMERS
  申请人：Merck Patent GmbH

  公开号：US20150069303A1

  公开（公告）日：2015-03-12

  The present invention relates to polymers which contain triarylamine repeating units that are substituted in the ortho position, methods for the production thereof, and the use thereof in electronic devices, especially in organic electroluminescent devices, so-called OLEDs (OLED=Organic Light Emitting Diode). The present invention also relates to organic electroluminescent devices which contain said polymers.

  本发明涉及含有取代在邻位的三芳胺重复单元的聚合物，其制备方法以及在电子器件中的应用，特别是在有机电致发光器件中，即所谓的OLED（OLED = 有机发光二极管）。本发明还涉及包含所述聚合物的有机电致发光器件。
• POLYMERS CONTAINING SUBSTITUTED OLIGO-TRIARYLAMINE UNITS AND ELECTROLUMINESCENCE DEVICES CONTAINING SUCH POLYMERS
  申请人：Merck Patent GmbH

  公开号：US20150076415A1

  公开（公告）日：2015-03-19

  The present invention relates to polymers containing oligo-triarylamine repetition units that are substituted in the ortho position, a method for the production thereof, and use thereof in electronic devices, particularly in organic electroluminescence devices, known as OLEDs (OLED=organic light emitting diodes). The present invention further relates to organic electroluminescence devices containing these polymers.

  本发明涉及含有寡聚三芳胺重复单元的聚合物，其在邻位上被取代，以及其制备方法和在电子设备中的使用，特别是在有机电致发光器件中，即OLED（有机发光二极管）。本发明还涉及含有这些聚合物的有机电致发光器件。